Review article · 2026 · Open access

Neuroinflammation in Alzheimer’s and Parkinson’s diseases: pathogenic mechanisms and therapeutic strategies

Qin-qin Wang, Qing-qing Sun, Yong-shun Guo, Shu Yin, Jiawei Zhou

Translational Neurodegeneration, 15(1) · Published 29 July 2026 · DOI 10.1186/s40035-026-00571-3

Free PDFView at the publisherCite this paper

In brief

“Neuroinflammation in Alzheimer’s and Parkinson’s diseases: pathogenic mechanisms and therapeutic strategies” is a 2026 review article by Qin-qin Wang and 4 co-authors, published in Translational Neurodegeneration. OpenAlex counts 2 citations as of 15 November 2026, which puts it in the top 5% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Translational Neurodegeneration.

Citations
2
Most cited in
2026 (2)
Field-weighted impact
1.17
References
517
Authors
5

Abstract

Neuroinflammation is increasingly recognized as a key contributor and amplifier associated with the pathogenesis of Alzheimer's disease (AD) and Parkinson's disease (PD). Neuroinflammation occurs throughout various stages of these diseases with expanding complexity. Currently, no effective therapies exist that specifically target neuroinflammatory processes in these disorders. In this review, we synthesize current understanding of central and peripheral inflammatory mechanisms implicated in both diseases. We illustrate how endogenous pathological triggers, such as amyloid-β (Aβ) peptide, hyperphosphorylated tau, and α-synuclein, activate glial cells, contributing to chronic neuroinflammation that exacerbates neurodegeneration. Additionally, peripheral factors, including systemic inflammation, environmental exposures, and gut-brain axis interactions, are discussed for their roles in modulating neuroinflammatory responses. Notably, the underappreciated roles of oligodendrocyte precursor cells and oligodendrocytes in neuroimmune crosstalk are also highlighted. Advanced methodologies, including glial cell imaging, single-cell transcriptomics, and human induced pluripotent stem cell-derived organoid models, are providing unprecedented insights into the molecular and cellular mechanisms underlying neuroinflammation. Finally, we evaluate emerging therapeutic strategies and ongoing clinical trials targeting neuroinflammatory pathways and analyze the potential of immunomodulatory approaches to slow disease progression. This comprehensive review emphasizes that precise targeting of neuroinflammation represents a tractable strategy for developing effective disease‑modifying treatments for AD and PD.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wang, Q.-Q., Sun, Q.-Q., Guo, Y.-S., Yin, S., & Zhou, J. (2026). Neuroinflammation in Alzheimer’s and Parkinson’s diseases: pathogenic mechanisms and therapeutic strategies. Translational Neurodegeneration, 15(1). https://doi.org/10.1186/s40035-026-00571-3

MLA 9

Wang, Qin-qin, et al. “Neuroinflammation in Alzheimer’s and Parkinson’s diseases: pathogenic mechanisms and therapeutic strategies.” Translational Neurodegeneration, vol. 15, no. 1, 2026. https://doi.org/10.1186/s40035-026-00571-3.

Chicago

Wang, Qin-qin, Qing-qing Sun, Yong-shun Guo, Shu Yin, and Jiawei Zhou. 2026. “Neuroinflammation in Alzheimer’s and Parkinson’s diseases: pathogenic mechanisms and therapeutic strategies.” Translational Neurodegeneration 15 (1). https://doi.org/10.1186/s40035-026-00571-3.

Harvard

Wang, Q.-Q. et al. (2026) ‘Neuroinflammation in Alzheimer’s and Parkinson’s diseases: pathogenic mechanisms and therapeutic strategies’, Translational Neurodegeneration, 15(1). doi:10.1186/s40035-026-00571-3.

IEEE

Q.-Q. Wang, Q.-Q. Sun, Y.-S. Guo, S. Yin, and J. Zhou, “Neuroinflammation in Alzheimer’s and Parkinson’s diseases: pathogenic mechanisms and therapeutic strategies,” Translational Neurodegeneration, vol. 15, no. 1, 2026, doi: 10.1186/s40035-026-00571-3.

BibTeX

@article{wang2026neuroinflammation,
  title     = {{Neuroinflammation in Alzheimer’s and Parkinson’s diseases: pathogenic mechanisms and therapeutic strategies}},
  author    = {Wang, Qin-qin and Sun, Qing-qing and Guo, Yong-shun and Yin, Shu and Zhou, Jiawei},
  journal   = {Translational Neurodegeneration},
  year      = {2026},
  volume    = {15},
  number    = {1},
  doi       = {10.1186/s40035-026-00571-3},
  url       = {https://doi.org/10.1186/s40035-026-00571-3}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms

  • neuroinflammation
  • Alzheimer's disease
  • Parkinson's disease
  • amyloid-beta
  • tau hyperphosphorylation
  • alpha-synuclein
  • glial activation
  • microglia

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Wang, Q.-Q., Sun, Q.-Q., Guo, Y.-S., Yin, S., & Zhou, J. (2026). Neuroinflammation in Alzheimer’s and Parkinson’s diseases: pathogenic mechanisms and therapeutic strategies. Translational Neurodegeneration, 15(1). https://doi.org/10.1186/s40035-026-00571-3

How many times has this paper been cited?

2 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Translational Neurodegeneration.

Who wrote this paper?

Qin-qin Wang, Qing-qing Sun, Yong-shun Guo, Shu Yin, Jiawei Zhou.

What is the DOI of this paper?

10.1186/s40035-026-00571-3. The permanent link is https://doi.org/10.1186/s40035-026-00571-3.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.